An Engineered Human Antibody Fab Fragment Specific for <i>Pseudomonas aeruginosa</i> PcrV Antigen Has Potent Antibacterial Activity
Mark Baer, Christopher Bebbington(Curtin University), Teiji Sawa(University of California, San Francisco), David R. Martinez(University of North Carolina at Chapel Hill), Jeanine P. Wiener-Kronish(Massachusetts General Hospital), Kenneth R. Luehrsen, Geoffrey Yarranton, Peter J. Flynn
Cited by 122
Related Papers
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k
Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product
|The Journal of Immunology|1998|546
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
|Cell Reports|2020|541
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
|Science Translational Medicine|2021|503